Evaluation of Effectiveness and Tolerability of Fondaparinux in the Management of Symptomatic Acute Coronary Syndrome: A Real-World Evidence-Based Study on an Indian Population

INTRODUCTION: Fondaparinux is a low molecular weight heparin anticoagulant used to manage the full spectrum of acute coronary syndrome (ACS) patients and has proved its efficacy and safety in multiple clinical trials. However, there are limited data available showing whether the same results could b...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalal, Jamshed, Mohan, J. C., Sathe, Sunil, Kumar, A. Sreenivas, Hiremath, Jagdish, Khan, Mohammed Yunus, Gaurav, Kumar, Mane, Amey, Pandit, Sucheta, Meel, Bhavesh, Subramaniyan, Anand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933594/
https://www.ncbi.nlm.nih.gov/pubmed/35138595
http://dx.doi.org/10.1007/s40119-022-00253-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933594/
https://www.ncbi.nlm.nih.gov/pubmed/35138595
http://dx.doi.org/10.1007/s40119-022-00253-x

Ejemplares similares